This brand name is authorized in Japan, South Africa
The drug RESCULA contains one active pharmaceutical ingredient (API):
|
1
Unoprostone
UNII 5M161S5O5P - UNOPROSTONE ISOPROPYL
|
|
Unoprostone is a prostaglandin (F2-alpha) analogue for the management of open-angle glaucoma and ocular hypertension. It is believed to reduce elevated intraocular pressure (IOP), by increasing the outflow of aqueous humor, but the exact mechanism is unknown at this time. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01EE02 | Unoprostone | S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1319732Q1035 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 35/15.4/0281 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
